Manufacturer
Fresenius Kabi Manufacturing SA (Pty) Ltd.
Contents
Potassium chloride
Indication
Hypokalaemia
Instruction
Adult: Peripheral or central line: ≤10 mEq/hour. Dose and rate of administration are dependent upon the ECG and serum K levels. Central line infusion: >10 mEq/hour, continuous ECG monitoring is highly recommended. Max: 20 mEq/hour; 2-3 mEq/kg daily. Dosage is individualised based on serum K levels.
Drug interaction
Increased risk of hyperkalaemia with ACE inhibitors (e.g. captopril), angiotensin II receptor antagonists, ciclosporin. May enhance ulcerogenic effect of solid oral dosage forms of K chloride with anticholinergic agents. May further decrease plasma K concentration with glucose infusion.Potentially Fatal: Increased risk of hyperkalaemia with potassium-sparing diuretics (e.g. spironolactone, amiloride, triamterene).
Malaysia
